TreeWAS – Variant ID: rs1149336

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z91.0 Personal history of allergy, other than to drugs and biological substances	0.000	0.932	0.068
E10.9 Without complications	0.033	0.967	0.000
N83.0 Follicular cyst of ovary	0.000	0.976	0.024
E10 Insulin-dependent diabetes mellitus	0.019	0.981	0.000
E10.5 With peripheral circulatory complications	0.019	0.981	0.000
Y57.9 Drug or medicament, unspecified	0.017	0.983	0.000
S82.60 Fracture of lateral malleolus (closed)	0.016	0.984	0.000
E10.7 With multiple complications	0.016	0.984	0.000
C77.0 Lymph nodes of head, face and neck	0.000	0.985	0.015
E10.3 With ophthalmic complications	0.015	0.985	0.000
E10.0 With coma	0.015	0.985	0.000
E10.6 With other specified complications	0.014	0.986	0.000
E10.8 With unspecified complications	0.014	0.986	0.000
E10.1 With ketoacidosis	0.012	0.988	0.000
Y57 Other and unspecified drugs and medicaments	0.012	0.988	0.000
Y57.6 Other diagnostic agents	0.010	0.989	0.000
Y57.8 Other drugs and medicaments	0.010	0.990	0.000
Z91 Personal history of risk-factors, not elsewhere classified	0.000	0.990	0.010
E10.4 With neurological complications	0.009	0.991	0.000
E10.2 With renal complications	0.009	0.991	0.000
Z91.5 Personal history of self-harm	0.000	0.991	0.009
Y57.7 Vitamins, not elsewhere classified	0.009	0.991	0.000
Y57.4 Pharmaceutical excipients	0.009	0.991	0.000
Y57.3 Alcohol deterrents	0.009	0.991	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.009	0.991	0.000
Y57.1 Lipotropic drugs	0.009	0.991	0.000
Y57.0 Appetite depressants [anorectics]	0.009	0.991	0.000
Y43.3 Other antineoplastic drugs	0.008	0.992	0.000
Z91.7 Personal history of female genital mutilation	0.000	0.993	0.007
Z91.4 Personal history of psychological trauma, not elsewhere classified	0.000	0.993	0.007
Z91.3 Personal history of unhealthy sleep-wake schedule	0.000	0.993	0.007
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.993	0.007
Y43 Primarily systemic agents	0.007	0.993	0.000
T92.8 Sequelae of other specified injuries of upper limb	0.007	0.993	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.993	0.007
S82.6 Fracture of lateral malleolus	0.007	0.993	0.000
T92 Sequelae of injuries of upper limb	0.007	0.993	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.007	0.993	0.000
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.007	0.993	0.000
Y43.4 Immunosuppressive agents	0.007	0.993	0.000
Z91.2 Personal history of poor personal hygiene	0.000	0.993	0.006
Z91.8 Personal history of other specified risk-factors, not elsewhere classified	0.000	0.993	0.006
M07.3 Other psoriatic arthropathies	0.000	0.994	0.006
T92.1 Sequelae of fracture of arm	0.006	0.994	0.000
Y57.5 X-ray contrast media	0.006	0.994	0.000
Y43.0 Antiallergic and antiemetic drugs	0.006	0.994	0.000
T92.4 Sequelae of injury of nerve of upper limb	0.006	0.994	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.006	0.994	0.000
H01.0 Blepharitis	0.000	0.994	0.006
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.005	0.995	0.000
Y43.9 Primarily systemic agent, unspecified	0.005	0.995	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.005	0.995	0.000
Y43.6 Enzymes, not elsewhere classified	0.005	0.995	0.000
Y43.5 Acidifying and alkalising agents	0.005	0.995	0.000
Y43.2 Antineoplastic natural products	0.005	0.995	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.005	0.995	0.000
Y43.1 Antineoplastic antimetabolites	0.005	0.995	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.000	0.995	0.005
S82.61 Fracture of lateral malleolus (open)	0.005	0.995	0.000
C49.2 Connective and soft tissue of lower limb, including hip	0.000	0.995	0.005
Y44 Agents primarily affecting blood constituents	0.005	0.995	0.000
H47.2 Optic atrophy	0.005	0.995	0.000
M07.38 Other psoriatic arthropathies (Other)	0.000	0.995	0.005
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.995	0.005
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.995	0.005
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.995	0.005
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.995	0.005
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.995	0.005
Z91.6 Personal history of other physical trauma	0.000	0.995	0.005
T92.9 Sequelae of unspecified injury of upper limb	0.005	0.995	0.000
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.005	0.995	0.000
Y44.5 Thrombolytic drugs	0.005	0.995	0.000
Y48.3 Local anaesthetics	0.005	0.995	0.000
M54.22 Cervicalgia (Cervical region)	0.000	0.995	0.005
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.995	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
A41.0 Septicaemia due to Staphylococcus aureus	0.004	0.996	0.000
H47 Other disorders of optic [2nd] nerve and visual pathways	0.004	0.996	0.000
H47.3 Other disorders of optic disk	0.004	0.996	0.000
Y58 Bacterial vaccines	0.004	0.996	0.000
C49.5 Connective and soft tissue of pelvis	0.000	0.996	0.004
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
C49 Malignant neoplasm of other connective and soft tissue	0.000	0.996	0.004
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
G12.2 Motor neuron disease	0.000	0.996	0.004
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.004	0.996	0.000
Y59 Other and unspecified vaccines and biological substances	0.004	0.996	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.004	0.996	0.000
Y44.7 Plasma substitutes	0.004	0.996	0.000
Y44.6 Natural blood and blood products	0.004	0.996	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.004	0.996	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.004	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y49.5 Other antipsychotics and neuroleptics	0.004	0.996	0.000
Y47.1 Benzodiazepines	0.004	0.996	0.000
Y44.2 Anticoagulants	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.004	0.996	0.000
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.996	0.003
H47.0 Disorders of optic nerve, not elsewhere classified	0.004	0.996	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.004	0.996	0.000
U80.0 Penicillin resistant agent	0.004	0.996	0.000
Y49.2 Other and unspecified antidepressants	0.004	0.996	0.000
C49.1 Connective and soft tissue of upper limb, including shoulder	0.000	0.996	0.004
Y46.4 Iminostilbenes	0.003	0.996	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.996	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.996	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.996	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.996	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.996	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.996	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.996	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.996	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
C49.4 Connective and soft tissue of abdomen	0.000	0.997	0.003
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
C49.0 Connective and soft tissue of head, face and neck	0.000	0.997	0.003
H47.7 Disorder of visual pathways, unspecified	0.003	0.997	0.000
H47.6 Disorders of visual cortex	0.003	0.997	0.000
H47.5 Disorders of other visual pathways	0.003	0.997	0.000
H47.4 Disorders of optic chiasm	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
H47.1 Papilloedema, unspecified	0.003	0.997	0.000
Y40.8 Other systemic antibiotics	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
N36.8 Other specified disorders of urethra	0.000	0.997	0.003
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
N32.3 Diverticulum of bladder	0.003	0.997	0.000
C49.8 Overlapping lesion of connective and soft tissue	0.000	0.997	0.003
C49.6 Connective and soft tissue of trunk, unspecified	0.000	0.997	0.003
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
Y55.5 Anticommon cold drugs	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y55.3 Antitussives	0.003	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
Y55.0 Oxytocic drugs	0.003	0.997	0.000
U80.1 Methicillin resistant agent	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
U80 Agent resistant to penicillin and related antibiotics	0.003	0.997	0.000
Y40 Systemic antibiotics	0.003	0.997	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.003	0.997	0.000
T92.0 Sequelae of open wound of upper limb	0.003	0.997	0.000
Y54.4 Loop [high-ceiling] diuretics	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
Y59.0 Viral vaccines	0.003	0.997	0.000
W07.0 Home	0.003	0.997	0.000
C49.3 Connective and soft tissue of thorax	0.000	0.997	0.003
Y54.5 Other diuretics	0.003	0.997	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
Y54.7 Agents affecting calcification	0.003	0.997	0.000
C49.9 Connective and soft tissue, unspecified	0.000	0.997	0.003
Y54.9 Mineral salts, not elsewhere classified	0.003	0.997	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.003	0.997	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.003	0.997	0.000
Y54.0 Mineralocorticoids	0.003	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
M07 Psoriatic and enteropathic arthropathies	0.000	0.997	0.003
Y41.5 Antiviral drugs	0.002	0.997	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.997	0.000
W29.9 Unspecified place	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.997	0.000
R73.9 Hyperglycaemia, unspecified	0.003	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.997	0.000
Y40.2 Chloramphenicol group	0.002	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.997	0.000
Y41.4 Anthelminthics	0.002	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.997	0.000
Y53.7 Emetics	0.002	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.002	0.997	0.000
Y53.5 Digestants	0.002	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.002	0.997	0.000
Y53.2 Stimulant laxatives	0.002	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.002	0.997	0.000
Y40.6 Rifamycins	0.002	0.997	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
H18.5 Hereditary corneal dystrophies	0.000	0.998	0.002
O35.1 Maternal care for (suspected) chromosomal abnormality in foetus	0.002	0.998	0.000
T80.2 Infections following infusion, transfusion and therapeutic injection	0.002	0.998	0.000
Y53.4 Other laxatives	0.002	0.998	0.000
H46-H48 Disorders of optic nerve and visual pathways	0.002	0.998	0.000
E73.9 Lactose intolerance, unspecified	0.002	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
Y41.0 Sulphonamides	0.002	0.998	0.000
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
H46 Optic neuritis	0.002	0.998	0.000
M07.6 Other enteropathic arthropathies	0.000	0.998	0.002
M07.5 Arthropathy in ulcerative colitis	0.000	0.998	0.002
M07.4 Arthropathy in Crohn's disease [regional enteritis]	0.000	0.998	0.002
M07.2 Psoriatic spondylitis	0.000	0.998	0.002
M07.1 Arthritis mutilans	0.000	0.998	0.002
M07.0 Distal interphalangeal psoriatic arthropathy	0.000	0.998	0.002
Y40.3 Macrolides	0.002	0.998	0.000
G12 Spinal muscular atrophy and related syndromes	0.000	0.998	0.002
I34.0 Mitral (valve) insufficiency	0.000	0.998	0.002
Z59.8 Other problems relating to housing and economic circumstances	0.000	0.998	0.002
M95.0 Acquired deformity of nose	0.000	0.998	0.002
Y40.9 Systemic antibiotic, unspecified	0.002	0.998	0.000
H48 Disorders of optic [2nd] nerve and visual pathways in diseases classified elsewhere	0.002	0.998	0.000
K41.9 Unilateral or unspecified femoral hernia, without obstruction or gangrene	0.002	0.998	0.000
Z83.3 Family history of diabetes mellitus	0.000	0.998	0.002
Q44.6 Cystic disease of liver	0.000	0.998	0.002
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.998	0.001
M07.09 Distal interphalangeal psoriatic arthropathy (Site unspecified)	0.000	0.998	0.002
M07.08 Distal interphalangeal proriatic arthropathy-Other	0.000	0.998	0.002
M07.07 Distal interphalangeal psoriatic arthropathy (Ankle and foot)	0.000	0.998	0.002
M07.06 Distal interphalangeal proriatic arthropathy-Lower leg	0.000	0.998	0.002
M07.05 Distal interphalangeal proriatic arthropathy-Pelvic/thigh	0.000	0.998	0.002
M07.04 Distal interphalangeal psoriatic arthropathy (Hand)	0.000	0.998	0.002
M07.03 Distal interphalangeal proriatic arthropathy-Forearm	0.000	0.998	0.002
M07.02 Distal interphalangeal proriatic arthropathy-Upper arm	0.000	0.998	0.002
M07.01 Distal interphalangeal proriatic arthropathy-Shldr region	0.000	0.998	0.002
M07.00 Distal interphalangeal psoriatic arthropathy (Multiple sites)	0.000	0.998	0.002
M07.19 Arthritis mutilans (Site unspecified)	0.000	0.998	0.002
M07.18 Arthritis mutilans (Other)	0.000	0.998	0.002
M07.17 Arthritis mutilans (Ankle and foot)	0.000	0.998	0.002
M07.16 Arthritis mutilans (Lower leg)	0.000	0.998	0.002
M07.15 Arthritis mutilans (Pelvic region and thigh)	0.000	0.998	0.002
M07.14 Arthritis mutilans (Hand)	0.000	0.998	0.002
M07.13 Arthritis mutilans (Forearm)	0.000	0.998	0.002
M07.12 Arthritis mutilans (Upper arm)	0.000	0.998	0.002
M07.11 Arthritis mutilans (Shoulder region)	0.000	0.998	0.002
M07.10 Arthritis mutilans (Multiple sites)	0.000	0.998	0.002
M07.29 Psoriatic spondylitis (Site unspecified)	0.000	0.998	0.002
M07.28 Psoriatic spondylitis (Other)	0.000	0.998	0.002
M07.27 Psoriatic spondylitis (Ankle and foot)	0.000	0.998	0.002
M07.26 Psoriatic spondylitis (Lower leg)	0.000	0.998	0.002
M07.25 Psoriatic spondylitis (Pelvic region and thigh)	0.000	0.998	0.002
M07.24 Psoriatic spondylitis (Hand)	0.000	0.998	0.002
M07.23 Psoriatic spondylitis (Forearm)	0.000	0.998	0.002
M07.22 Psoriatic spondylitis (Upper arm)	0.000	0.998	0.002
M07.21 Psoriatic spondylitis (Shoulder region)	0.000	0.998	0.002
M07.20 Psoriatic spondylitis (Multiple sites)	0.000	0.998	0.002
M07.49 Arthropathy in Crohn's disease [regional enteritis] (Site unspecified)	0.000	0.998	0.002
M07.48 Arthropathy in Crohn's disease [regional enteritis] (Other)	0.000	0.998	0.002
M07.47 Arthropathy in Crohn's disease [regional enteritis] (Ankle and foot)	0.000	0.998	0.002
M07.46 Arthropathy in Crohn's disease [regional enteritis] (Lower leg)	0.000	0.998	0.002
M07.45 Arthropathy in Crohn's disease [regional enteritis] (Pelvic region and thigh)	0.000	0.998	0.002
M07.44 Arthropathy in Crohn's disease [regional enteritis] (Hand)	0.000	0.998	0.002
M07.43 Arthropathy in Crohn's disease [regional enteritis] (Forearm)	0.000	0.998	0.002
M07.42 Arthropathy in Crohn's disease [regional enteritis] (Upper arm)	0.000	0.998	0.002
M07.41 Arthropathy in Crohn's disease [regional enteritis] (Shoulder region)	0.000	0.998	0.002
M07.40 Arthropathy in Crohn's disease [regional enteritis] (Multiple sites)	0.000	0.998	0.002
M07.59 Arthropathy in ulcerative colitis (Site unspecified)	0.000	0.998	0.002
M07.58 Arthropathy in ulcerative colitis (Other)	0.000	0.998	0.002
M07.57 Arthropathy in ulcerative colitis (Ankle and foot)	0.000	0.998	0.002
M07.56 Arthropathy in ulcerative colitis (Lower leg)	0.000	0.998	0.002
M07.55 Arthropathy in ulcerative colitis (Pelvic region and thigh)	0.000	0.998	0.002
M07.54 Arthropathy in ulcerative colitis (Hand)	0.000	0.998	0.002
M07.53 Arthropathy in ulcerative colitis (Forearm)	0.000	0.998	0.002
M07.52 Arthropathy in ulcerative colitis (Upper arm)	0.000	0.998	0.002
M07.51 Arthropathy in ulcerative colitis (Shoulder region)	0.000	0.998	0.002
M07.50 Arthropathy in ulcerative colitis (Multiple sites)	0.000	0.998	0.002
M07.69 Other enteropathic arthropathies (Site unspecified)	0.000	0.998	0.002
M07.68 Other enteropathic arthropathies (Other)	0.000	0.998	0.002
M07.67 Other enteropathic arthropathies (Ankle and foot)	0.000	0.998	0.002
M07.66 Other enteropathic arthropathies (Lower leg)	0.000	0.998	0.002
M07.65 Other enteropathic arthropathies (Pelvic region and thigh)	0.000	0.998	0.002
M07.64 Other enteropathic arthropathies (Hand)	0.000	0.998	0.002
M07.63 Other enteropathic arthropathies (Forearm)	0.000	0.998	0.002
M07.62 Other enteropathic arthropathies (Upper arm)	0.000	0.998	0.002
M07.61 Other enteropathic arthropathies (Shoulder region)	0.000	0.998	0.002
M07.60 Other enteropathic arthropathies (Multiple sites)	0.000	0.998	0.002
M89.87 Other specified disorders of bone (Ankle and foot)	0.000	0.998	0.002
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
M19.93 Arthrosis, unspecified (Forearm)	0.000	0.998	0.002
Y88.3 Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient or of later complication, without mention of misadventure at the time of the procedure	0.000	0.998	0.002
G12.9 Spinal muscular atrophy, unspecified	0.000	0.998	0.002
G12.8 Other spinal muscular atrophies and related syndromes	0.000	0.998	0.002
G12.1 Other inherited spinal muscular atrophy	0.000	0.998	0.002
G12.0 Infantile spinal muscular atrophy, type I [Werdnig-Hoffman]	0.000	0.998	0.002
G54.9 Nerve root and plexus disorder, unspecified	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.001	0.998	0.001
W29 Contact with other powered hand tools and household machinery	0.002	0.998	0.000
Q38.7 Pharyngeal pouch	0.000	0.998	0.002
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
K90.0 Coeliac disease	0.000	0.998	0.002
W44.0 Home	0.002	0.998	0.000
S83.2 Tear of meniscus, current	0.000	0.998	0.002
Y42.2 Antithyroid drugs	0.002	0.998	0.000
H48.8 Other disorders of optic nerve and visual pathways in diseases classified elsewhere	0.001	0.998	0.000
H48.1 Retrobulbar neuritis in diseases classified elsewhere	0.001	0.998	0.000
H48.0 Optic atrophy in diseases classified elsewhere	0.001	0.998	0.000
H54.7 Unspecified visual loss	0.002	0.998	0.000
T85.5 Mechanical complication of gastro-intestinal prosthetic devices, implants and grafts	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Z59.0 Homelessness	0.000	0.998	0.002
Z97.8 Presence of other specified devices	0.000	0.998	0.002
E10-E14 Diabetes mellitus	0.002	0.998	0.000
C50.1 Central portion of breast	0.000	0.998	0.002
H60.3 Other infective otitis externa	0.002	0.998	0.000
F81.9 Developmental disorder of scholastic skills, unspecified	0.002	0.998	0.000
W29.8 Other specified place	0.001	0.998	0.000
W29.6 Industrial and construction area	0.001	0.998	0.000
W29.0 Home	0.001	0.998	0.000
W29.7 Farm	0.001	0.998	0.000
W29.4 Street and highway	0.001	0.998	0.000
W29.3 Sports and athletics area	0.001	0.998	0.000
W29.2 School, other institution and public administrative area	0.001	0.998	0.000
W29.1 Residential institution	0.001	0.998	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
H01 Other inflammation of eyelid	0.000	0.998	0.002
K26.4 Chronic or unspecified with haemorrhage	0.000	0.998	0.002
M19.90 Arthrosis, unspecified (Multiple sites)	0.002	0.998	0.000
K75.9 Inflammatory liver disease, unspecified	0.002	0.998	0.000
W50.9 Unspecified place	0.001	0.998	0.000
M77.97 Enthesopathy, unspecified (Ankle and foot)	0.000	0.998	0.001
C80.9 Malignant neoplasm, unspecified	0.000	0.998	0.002
Y42.1 Thyroid hormones and substitutes	0.001	0.998	0.000
M54.16 Radiculopathy (Lumbar region)	0.001	0.998	0.000
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.000	0.998	0.001
Q21.0 Ventricular septal defect	0.001	0.998	0.000
W29.5 Trade and service area	0.001	0.998	0.000
Q44 Congenital malformations of gallbladder, bile ducts and liver	0.000	0.998	0.001
K75.8 Other specified inflammatory liver diseases	0.001	0.999	0.000
N85.4 Malposition of uterus	0.001	0.999	0.000
G54.6 Phantom limb syndrome with pain	0.001	0.999	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.000	0.999	0.001
W44 Foreign body entering into or through eye or natural orifice	0.001	0.999	0.000
Z59 Problems related to housing and economic circumstances	0.000	0.999	0.001
O35.9 Maternal care for (suspected) foetal abnormality and damage, unspecified	0.001	0.999	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.999	0.000
Y52 Agents primarily affecting the cardiovascular system	0.001	0.999	0.000
B25.9 Cytomegaloviral disease, unspecified	0.001	0.999	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.001	0.999	0.000
Z59.9 Problem relating to housing and economic circumstances, unspecified	0.000	0.999	0.001
E12 Malnutrition-related diabetes mellitus	0.001	0.999	0.000
S02.60 Fracture of mandible (closed)	0.000	0.999	0.001
W29.09 Contact with other powered hand tools and household machinery; Home; During unspecified activity	0.001	0.999	0.000
W29.62 Contact with other powered hand tools and household machinery; Industrial and construction area ;While working for income	0.001	0.999	0.000
W29.82 Contact with other powered hand tools and household machinery; Other specified places ;While working for income	0.001	0.999	0.000
H01.1 Non-infectious dermatoses of eyelid	0.000	0.999	0.001
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.001	0.999	0.000
K75.3 Granulomatous hepatitis, not elsewhere classified	0.001	0.999	0.000
Y42.7 Androgens and anabolic congeners	0.001	0.999	0.000
A41.2 Septicaemia due to unspecified staphylococcus	0.001	0.999	0.000
K75 Other inflammatory liver diseases	0.001	0.999	0.000
H60.1 Cellulitis of external ear	0.001	0.999	0.000
E13 Other specified diabetes mellitus	0.001	0.999	0.000
K74.6 Other and unspecified cirrhosis of liver	0.001	0.999	0.000
K75.4 Autoimmune hepatitis	0.001	0.999	0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.001	0.999	0.000
Q44.7 Other congenital malformations of liver	0.000	0.999	0.001
Q44.5 Other congenital malformations of bile ducts	0.000	0.999	0.001
Q44.4 Choledochal cyst	0.000	0.999	0.001
Q44.3 Congenital stenosis and stricture of bile ducts	0.000	0.999	0.001
Q44.2 Atresia of bile ducts	0.000	0.999	0.001
Q44.1 Other congenital malformations of gallbladder	0.000	0.999	0.001
Q44.0 Agenesis, aplasia and hypoplasia of gallbladder	0.000	0.999	0.001
Q38 Other congenital malformations of tongue, mouth and pharynx	0.000	0.999	0.001
W07 Fall involving chair	0.001	0.999	0.000
O36.6 Maternal care for excessive foetal growth	0.000	0.999	0.001
Q22.1 Congenital pulmonary valve stenosis	0.001	0.999	0.000
G54 Nerve root and plexus disorders	0.001	0.999	0.000
M89.84 Other specified disorders of bone (Hand)	0.000	0.999	0.001
W44.8 Other specified place	0.001	0.999	0.000
Z59.7 Insufficient social insurance and welfare support	0.000	0.999	0.001
Z59.6 Low income	0.000	0.999	0.001
Z59.5 Extreme poverty	0.000	0.999	0.001
Z59.4 Lack of adequate food	0.000	0.999	0.001
Z59.3 Problems related to living in residential institution	0.000	0.999	0.001
Z59.2 Discord with neighbours, lodgers and landlord	0.000	0.999	0.001
Z59.1 Inadequate housing	0.000	0.999	0.001
G54.8 Other nerve root and plexus disorders	0.001	0.999	0.000
H27.0 Aphakia	0.000	0.999	0.001
W44.9 Unspecified place	0.001	0.999	0.000
W44.5 Trade and service area	0.001	0.999	0.000
W44.7 Farm	0.001	0.999	0.000
W44.6 Industrial and construction area	0.001	0.999	0.000
W44.4 Street and highway	0.001	0.999	0.000
W44.3 Sports and athletics area	0.001	0.999	0.000
W44.2 School, other institution and public administrative area	0.001	0.999	0.000
W44.1 Residential institution	0.001	0.999	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.999	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.001	0.999	0.000
Y52.7 Peripheral vasodilators	0.001	0.999	0.000
A41.4 Septicaemia due to anaerobes	0.001	0.999	0.000
E12.9 Without complications	0.001	0.999	0.000
E12.8 With unspecified complications	0.001	0.999	0.000
E12.7 With multiple complications	0.001	0.999	0.000
E12.6 With other specified complications	0.001	0.999	0.000
E12.5 With peripheral circulatory complications	0.001	0.999	0.000
E12.4 With neurological complications	0.001	0.999	0.000
E12.3 With ophthalmic complications	0.001	0.999	0.000
E12.2 With renal complications	0.001	0.999	0.000
E12.1 With ketoacidosis	0.001	0.999	0.000
E12.0 With coma	0.001	0.999	0.000
F01.9 Vascular dementia, unspecified	0.001	0.999	0.000
H61.3 Acquired stenosis of external ear canal	0.001	0.999	0.000
X59.4 Street and highway	0.001	0.999	0.000
Q28 Other congenital malformations of circulatory system	0.001	0.999	0.000
M82.11 Osteoporosis in endocrine disorders (Shoulder region)	0.001	0.999	0.000
K75.2 Nonspecific reactive hepatitis	0.001	0.999	0.000
K75.1 Phlebitis of portal vein	0.001	0.999	0.000
Q43.3 Congenital malformations of intestinal fixation	0.000	0.999	0.001
Y42.0 Glucocorticoids and synthetic analogs	0.001	0.999	0.000
D21.2 Connective and other soft tissue of lower limb, including hip	0.001	0.999	0.000
D21.1 Connective and other soft tissue of upper limb, including shoulder	0.001	0.999	0.000
E13.8 With unspecified complications	0.001	0.999	0.000
E13.7 With multiple complications	0.001	0.999	0.000
E13.6 With other specified complications	0.001	0.999	0.000
E13.5 With peripheral circulatory complications	0.001	0.999	0.000
E13.4 With neurological complications	0.001	0.999	0.000
E13.3 With ophthalmic complications	0.001	0.999	0.000
E13.2 With renal complications	0.001	0.999	0.000
E13.1 With ketoacidosis	0.001	0.999	0.000
E13.0 With coma	0.001	0.999	0.000
G54.5 Neuralgic amyotrophy	0.001	0.999	0.000
G72.9 Myopathy, unspecified	0.001	0.999	0.000
H02.9 Disorder of eyelid, unspecified	0.001	0.999	0.000
M89.8 Other specified disorders of bone	0.000	0.999	0.001
O90.8 Other complications of the puerperium, not elsewhere classified	0.000	0.999	0.001
Q28.0 Arteriovenous malformation of precerebral vessels	0.001	0.999	0.000
W21.9 Unspecified place	0.001	0.999	0.000
G54.0 Brachial plexus disorders	0.001	0.999	0.000
Q38.8 Other congenital malformations of pharynx	0.000	0.999	0.001
Q38.6 Other congenital malformations of mouth	0.000	0.999	0.001
Q38.5 Congenital malformations of palate, not elsewhere classified	0.000	0.999	0.001
Q38.4 Congenital malformations of salivary glands and ducts	0.000	0.999	0.001
Q38.3 Other congenital malformations of tongue	0.000	0.999	0.001
Q38.2 Macroglossia	0.000	0.999	0.001
Q38.1 Ankyloglossia	0.000	0.999	0.001
W07.2 School, other institution and public administrative area	0.001	0.999	0.000
W07.8 Other specified place	0.001	0.999	0.000
W07.7 Farm	0.001	0.999	0.000
W07.6 Industrial and construction area	0.001	0.999	0.000
W07.4 Street and highway	0.001	0.999	0.000
W07.3 Sports and athletics area	0.001	0.999	0.000
W07.1 Residential institution	0.001	0.999	0.000
W49.6 Industrial and construction area	0.001	0.999	0.000
Q22 Congenital malformations of pulmonary and tricuspid valves	0.001	0.999	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.000	0.999	0.001
G54.7 Phantom limb syndrome without pain	0.001	0.999	0.000
G54.4 Lumbosacral root disorders, not elsewhere classified	0.001	0.999	0.000
G54.3 Thoracic root disorders, not elsewhere classified	0.001	0.999	0.000
G54.1 Lumbosacral plexus disorders	0.001	0.999	0.000
H01.8 Other specified inflammation of eyelid	0.000	0.999	0.001
Q21.3 Tetralogy of Fallot	0.001	0.999	0.000
T93.2 Sequelae of other fractures of lower limb	0.001	0.999	0.000
V09.0 Pedestrian injured in nontraffic accident involving other and unspecified motor vehicles	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations